Year archive

Ocumension Therapeutics — 2024 filings

All 130 regulatory filings released by Ocumension Therapeutics (1477) in 2024, sourced directly from the official regulator.

130 Filings

2024 Period

2024 filings (130)

Filing	Released	Lang
Next Day Disclosure Return Transaction in Own Shares	2024-12-31	English
Next Day Disclosure Return Transaction in Own Shares	2024-12-30	English
Next Day Disclosure Return Transaction in Own Shares	2024-12-27	English
Next Day Disclosure Return Transaction in Own Shares	2024-12-24	English
Next Day Disclosure Return Transaction in Own Shares	2024-12-19	English
Next Day Disclosure Return Transaction in Own Shares	2024-12-18	English
Next Day Disclosure Return Transaction in Own Shares	2024-12-17	English
Next Day Disclosure Return Transaction in Own Shares	2024-12-16	English
Next Day Disclosure Return Transaction in Own Shares	2024-12-13	English
Next Day Disclosure Return Transaction in Own Shares	2024-12-12	English
Next Day Disclosure Return Transaction in Own Shares	2024-12-10	English
Next Day Disclosure Return Transaction in Own Shares	2024-12-09	English
Next Day Disclosure Return Transaction in Own Shares	2024-12-06	English
Next Day Disclosure Return Transaction in Own Shares	2024-12-05	English
Next Day Disclosure Return Transaction in Own Shares	2024-12-04	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 November 2024 Regulatory Filings	2024-12-04	English
VOLUNTARY ANNOUNCEMENT PATIENT ENROLLMENT COMPLETED IN THE SECOND PHASE III CLINICAL TRIAL OF OT-301 IN CHINA Regulatory Filings	2024-12-03	English
Next Day Disclosure Return Transaction in Own Shares	2024-12-02	English
Next Day Disclosure Return Transaction in Own Shares	2024-11-29	English
Next Day Disclosure Return Transaction in Own Shares	2024-11-28	English
Next Day Disclosure Return Transaction in Own Shares	2024-11-27	English
Next Day Disclosure Return Transaction in Own Shares	2024-11-26	English
Next Day Disclosure Return Transaction in Own Shares	2024-11-25	English
Next Day Disclosure Return Transaction in Own Shares	2024-11-22	English
Next Day Disclosure Return Transaction in Own Shares	2024-11-21	English
Next Day Disclosure Return Transaction in Own Shares	2024-11-20	English
Next Day Disclosure Return Transaction in Own Shares	2024-11-19	English
Next Day Disclosure Return Transaction in Own Shares	2024-11-18	English
Next Day Disclosure Return Transaction in Own Shares	2024-11-15	English
Next Day Disclosure Return Transaction in Own Shares	2024-11-14	English
Next Day Disclosure Return Transaction in Own Shares	2024-11-13	English
Next Day Disclosure Return Transaction in Own Shares	2024-11-12	English
Next Day Disclosure Return Transaction in Own Shares	2024-11-11	English
Next Day Disclosure Return Transaction in Own Shares	2024-11-08	English
Next Day Disclosure Return Transaction in Own Shares	2024-11-07	English
Next Day Disclosure Return Transaction in Own Shares	2024-11-06	English
Next Day Disclosure Return Transaction in Own Shares	2024-11-06	English
Next Day Disclosure Return Transaction in Own Shares	2024-11-04	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 October 2024 Regulatory Filings	2024-11-01	English
Next Day Disclosure Return Transaction in Own Shares	2024-11-01	English
Next Day Disclosure Return Transaction in Own Shares	2024-10-31	English
Next Day Disclosure Return Transaction in Own Shares	2024-10-30	English
Next Day Disclosure Return Transaction in Own Shares	2024-10-29	English
Next Day Disclosure Return Transaction in Own Shares	2024-10-28	English
Next Day Disclosure Return Transaction in Own Shares	2024-10-25	English
List of Directors and their Role and Function Governance Information	2024-10-21	English
RESIGNATION OF A NON-EXECUTIVE DIRECTOR Board/Management Information	2024-10-21	English
Next Day Disclosure Return Transaction in Own Shares	2024-10-17	English
Next Day Disclosure Return Transaction in Own Shares	2024-10-16	English
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON OCTOBER 16, 2024 Declaration of Voting Results & Voting Rights Announcements	2024-10-16	English
Next Day Disclosure Return Transaction in Own Shares	2024-10-15	English
Next Day Disclosure Return Transaction in Own Shares	2024-10-14	English
Next Day Disclosure Return Transaction in Own Shares	2024-10-10	English
Next Day Disclosure Return Transaction in Own Shares	2024-10-09	English
Next Day Disclosure Return Transaction in Own Shares	2024-10-08	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 September 2024 Regulatory Filings	2024-10-07	English
Documents on Display Regulatory Filings	2024-09-29	English
FORM OF PROXY FOR THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON WEDNESDAY, OCTOBER 16, 2024 Proxy Solicitation & Information Statement	2024-09-29	English
NOTICE OF EXTRAORDINARY GENERAL MEETING Proxy Solicitation & Information Statement	2024-09-29	English
(1) VERY SUBSTANTIAL ACQUISITION IN RELATION TO ACQUISITION OF TRANSFERRED PRODUCTS, IN-LICENSING OF LICENSED PRODUCTS AND PROPOSED ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE; (2) CONTI Proxy Solicitation & Information Statement	2024-09-29	English
CLOSURE OF REGISTER OF MEMBERS FOR THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON OCTOBER 16, 2024 Declaration of Voting Results & Voting Rights Announcements	2024-09-27	English
Next Day Disclosure Return Transaction in Own Shares	2024-09-26	English
Next Day Disclosure Return Transaction in Own Shares	2024-09-25	English
Next Day Disclosure Return Transaction in Own Shares	2024-09-24	English
VOLUNTARY ANNOUNCEMENT NEW DRUG APPLICATION OF OT-502 ACCEPTED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION Regulatory Filings	2024-09-23	English
Next Day Disclosure Return Transaction in Own Shares	2024-09-19	English
VOLUNTARY ANNOUNCEMENT NEW DRUG APPLICATION OF OT-1001 APPROVED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION Regulatory Filings	2024-09-19	English
FURTHER DELAY IN DESPATCH OF CIRCULAR IN RELATION TO (1) VERY SUBSTANTIAL ACQUISITION IN RELATION TO ACQUISITION OF TRANSFERRED PRODUCTS, IN-LICENSING OF LICENSED PRODUCTS AND PROPOSED ISSUE OF CONSID Regulatory Filings	2024-09-17	English
2024 Interim Report Interim / Quarterly Report	2024-09-10	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 August 2024 Regulatory Filings	2024-09-03	English
DELAY IN DESPATCH OF CIRCULAR IN RELATION TO (1) VERY SUBSTANTIAL ACQUISITION IN RELATION TO ACQUISITION OF TRANSFERRED PRODUCTS, IN-LICENSING OF LICENSED PRODUCTS AND PROPOSED ISSUE OF CONSIDERATION Regulatory Filings	2024-09-02	English
Next Day Disclosure Return Transaction in Own Shares	2024-08-30	English
Next Day Disclosure Return Regulatory Filings	2024-08-29	English
Next Day Disclosure Return (Resubmission) Transaction in Own Shares	2024-08-29	English
Next Day Disclosure Return Transaction in Own Shares	2024-08-28	English
Next Day Disclosure Return Transaction in Own Shares	2024-08-27	English
Next Day Disclosure Return Transaction in Own Shares	2024-08-26	English
Next Day Disclosure Return Transaction in Own Shares	2024-08-23	English
Next Day Disclosure Return Transaction in Own Shares	2024-08-22	English
VOLUNTARY ANNOUNCEMENT PROPOSED ON-MARKET SHARE REPURCHASE Transaction in Own Shares	2024-08-22	English
Next Day Disclosure Return Transaction in Own Shares	2024-08-21	English
Next Day Disclosure Return Transaction in Own Shares	2024-08-20	English
Next Day Disclosure Return Transaction in Own Shares	2024-08-19	English
Next Day Disclosure Return Transaction in Own Shares	2024-08-16	English
Next Day Disclosure Return Transaction in Own Shares	2024-08-15	English
(1) VERY SUBSTANTIAL ACQUISITION IN RELATION TO ACQUISITION OF TRANSFERRED PRODUCTS, IN-LICENSING OF LICENSED PRODUCTS AND PROPOSED ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE AND (2) CONTINU Capital/Financing Update	2024-08-12	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2024 Interim / Quarterly Report	2024-08-12	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 July 2024 Regulatory Filings	2024-08-05	English
NOTICE OF BOARD MEETING Regulatory Filings	2024-07-30	English
VOLUNTARY ANNOUNCEMENT BIOLOGIC LICENSE APPLICATION FOR OT-702 ACCEPTED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION Regulatory Filings	2024-07-16	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 June 2024 Regulatory Filings	2024-07-04	English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 20, 2024 Declaration of Voting Results & Voting Rights Announcements	2024-06-20	English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 May 2024 Regulatory Filings	2024-06-06	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 May 2024 Regulatory Filings	2024-06-03	English
Documents on Display Regulatory Filings	2024-05-23	English
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON THURSDAY, JUNE 20, 2024 AGM Information	2024-05-23	English
NOTICE OF ANNUAL GENERAL MEETING AGM Information	2024-05-23	English
PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES; PROPOSED RE-ELECTION OF RETIRING DIRECTORS; PROPOSED RE-APPOINTMENT OF AUDITOR; PROPOSED AMENDMENTS TO THE 2 AGM Information	2024-05-23	English
Next Day Disclosure Return Transaction in Own Shares	2024-05-21	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 April 2024 Regulatory Filings	2024-05-06	English
2023 Environmental, Social and Governance Report Regulatory Filings	2024-04-25	English
2023 Annual Report Regulatory Filings	2024-04-25	English
VOLUNTARY ANNOUNCEMENT PRIMARY ENDPOINTS ACHIEVED IN THE PHASE III CLINICAL TRIAL OF OT-502 IN CHINA Regulatory Filings	2024-04-15	English
VOLUNTARY ANNOUNCEMENT COMPLETION OF THE PHASE III CLINICAL TRIAL OF OT-702 IN CHINA Regulatory Filings	2024-04-08	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 March 2024 Share Issue/Capital Change	2024-04-03	English
(I) PROPOSED AMENDMENTS TO THE 2021 SHARE OPTION SCHEME; AND (II) PROPOSED AMENDMENTS TO THE 2021 SHARE AWARD SCHEME Regulatory Filings	2024-03-21	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023 Annual Report	2024-03-21	English
VOLUNTARY ANNOUNCEMENT PRIMARY ENDPOINTS ACHIEVED IN THE PHASE II CLINICAL TRIAL OF OT-202 Regulatory Filings	2024-03-14	English
DATE OF BOARD MEETING Regulatory Filings	2024-03-07	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 29 February 2024 Share Issue/Capital Change	2024-03-01	English
Notification Letter to Non-registered Shareholders and Reply Form - Arrangement of Electronic Dissemination of Corporate Communications Regulatory Filings	2024-02-09	English
Notification Letter to Registered Shareholders and Reply Form - Arrangement of Electronic Dissemination of Corporate Communications Regulatory Filings	2024-02-09	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 January 2024 Regulatory Filings	2024-02-01	English
Next Day Disclosure Return Transaction in Own Shares	2024-01-19	English
Next Day Disclosure Return Transaction in Own Shares	2024-01-18	English
Next Day Disclosure Return Transaction in Own Shares	2024-01-17	English
DISCLOSEABLE TRANSACTION DISPOSAL OF SHARES IN EYEPOINT PHARMACEUTICALS, INC. Capital/Financing Update	2024-01-17	English
Next Day Disclosure Return Transaction in Own Shares	2024-01-16	English
Next Day Disclosure Return Transaction in Own Shares	2024-01-15	English
Next Day Disclosure Return Transaction in Own Shares	2024-01-12	English
Next Day Disclosure Return (Resubmission) Transaction in Own Shares	2024-01-11	English
Next Day Disclosure Return (Resubmission) Transaction in Own Shares	2024-01-11	English
Next Day Disclosure Return Transaction in Own Shares	2024-01-10	English
Next Day Disclosure Return Transaction in Own Shares	2024-01-09	English
Next Day Disclosure Return Transaction in Own Shares	2024-01-08	English
Next Day Disclosure Return Transaction in Own Shares	2024-01-05	English
Next Day Disclosure Return Transaction in Own Shares	2024-01-04	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 December 2023 Share Issue/Capital Change	2024-01-03	English
Next Day Disclosure Return Transaction in Own Shares	2024-01-03	English
Next Day Disclosure Return Transaction in Own Shares	2024-01-02	English